PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
04-Nov-2020 SOTIO to Present New Data on the IL-15 Superagonist SO-C101 at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting B3C newswire
04-Nov-2020 Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows Thermo Fisher Scientific
04-Nov-2020 EVOTEC TO ATTEND UPCOMING INVESTOR CONFERENCES Evotec SE
04-Nov-2020 Calliditas closes acquisition of a controlling interest in Genkyotex SA Calliditas
04-Nov-2020 Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure Showing Functional Reversal and Myocardial Rejuvenation B3C newswire
04-Nov-2020 M1 Kliniken AG: Number of treatments increase by almost 20 % in Q3-2020. Comprehensive hygiene concept ensures continuation of treatment activities. M1 Kliniken AG
04-Nov-2020 Relief Appoints J. Paul Waymack, M.D., Sc.D. as Consultant to Strengthen Management Team RELIEF THERAPEUTICS Holdings AG
04-Nov-2020 Jubilant Therapeutics to Participate in Upcoming Investor Conferences Jubilant Therapeutics Inc.
03-Nov-2020 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Akebia Therapeutics
03-Nov-2020 Cumberland Pharmaceuticals To Announce Third Quarter 2020 Financial Results Cumberland Pharmaceuticals Inc.
03-Nov-2020 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Blueprint Medicines Corporation
03-Nov-2020 Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products Sanofi
03-Nov-2020 VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan VFMCRP and ChemoCentryx
03-Nov-2020 Sanofi offers to acquire Kiadis for €308 million Sanofi
03-Nov-2020 MediClin AG: MEDICLIN publishes forecast for fiscal year 2020 MediClin AG
03-Nov-2020 An industry Outlook: latest regulatory challenges in Pre-filled syringe innovation SMi Group Ltd
03-Nov-2020 Epigenomics AG: Capital reduction and further authorization to issue convertible bonds with backstop investor planned Epigenomics AG
03-Nov-2020 AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases FDA approved prescription drugs Lysodren® and Metopirone® in the United States AllianceRx Walgreens Prime
03-Nov-2020 VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan VFMCRP, ChemoCentryx
03-Nov-2020 ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors ExeVir Bio